Founder and CEO of @insitro, Machine Learning pioneer, co-founder of Coursera, adjunct CS Professor at Stanford, avid traveler
San Francisco Bay Area
Joined September 2012
- Tweets 59
- Following 5
- Followers 26,240
- Likes 6
I am so excited to welcome Amy to our Board of Directors! Her unique experience in combining technology and data science with drug development and regulatory policy will be invaluable to us as we move to the next phase of our journey at insitro.
We're thrilled to welcome Dr. Amy Abernethy to our BOD! A clinical research pioneer & hematologist-oncologist, her dedication to data-driven healthcare innovation and transformative drug development on behalf of patients align perfectly with our mission. businesswire.com/news/home/2…
Come join our exec team at @insitro - tinyurl.com/4uccv62j: lead our ML efforts and make a difference to patients! We are building an ML-enabled platform to advance medicines for patients in neuroscience, metabolism and oncology diseases. (Read more: tinyurl.com/mwe4xrdb).
Excited to welcome Mike to the @insitro team! Mike has an incredible track record of innovation in clinical trial design, to deliver on the goal of accelerating impact to patients. His contributions will be transformative as we enter the next phase of our journey.
We’re thrilled to welcome Dr. S. Michael Rothenberg as insitro’s CMO. With 2 decades of clinical care & drug development experience, his innovations in data-driven trial design will be critical as we advance our pipeline toward the clinic. businesswire.com/news/home/2…
Thank you @matthewherper for the insightful coverage of our team's scientific progress, highlighting how #AI and #Biology can advance us towards our mission of bringing better medicines to patients. For more details, watch our presentation tomorrow at #jpm2024!
We’re excited to share @matthewherper’s new story in @statnews, which spotlights 3 new research papers posted online describing exciting developments emerging from our #ML platform across our core therapeutic areas. Read more below. #JPM24
It's been an incredible year for us at insitro, with so much progress on our platform, our science, our team, and our pipeline. And now, to top it off, we are so excited to launch our new website - beautiful yet substantive - which truly tells our differentiated story.
We're thrilled to launch a new insitro.com, an immersive portal into our platform, pipeline, science, technology & culture – the intersection of which makes us a company like no other! Check out our teaser video & bookmark us to follow our science, news & progress.
It was such an honor to have the privilege of interviewing @SueDHellmann as the opening plenary at our invivo week at @insitro. She inspired all of us in our journey to use #MachineLearning towards bringing better medicines, faster to patients who can benefit the most.
It's go time! #inVivoWeek2023 officially started today at insitro with an incredible, inspiring fireside chat between trailblazing healthcare leader @SueDHellmann and our Founder & CEO @DaphneKoller. Brace yourself for a week of learning, collaboration & boundless #innovation!
One of the most rewarding aspects of building insitro is our amazing team. I'm thrilled to welcome Philip Tagari, who joins as our inaugural chief scientific officer after serving as a research leader & drug hunter at Amgen for 24 years. Welcome, Philip! tinyurl.com/4crwhyew
I am honored to be included in the @Forbes 2022 “50 over 50” list (tinyurl.com/3w544a57) with incredible women leaders having broad impact across society and industry. It's a privilege to have helped form and build transformative companies @insitro, @coursera, @engageli.
Deeply honored to receive the 2022 Technical Leadership Abie Award from @AnitaB_org this week. I dedicate this award to the incredible young women I've mentored & worked with, including my 2 daughters. May your careers be free of discrimination, allowing your talents to shine!
I'm proud to be the recipient of the 2022 Technical Leadership Abie Award! I look forward to joining the largest gathering of women and non-binary technologists in September as we all strive to transform the future of tech. #GHC22 #NextIsNow #WomenInTech
Redun has greatly eased development of complex pipelines at @insitro and enabled reproducible science. Many thanks to @mattrasmus and team for sharing this important capability with the broader community.
Thanks to the AWS team for featuring Matt Rasmussen
(@mattrasmus), our VP Software Engineering, in today's HPC blog. We are grateful for the opportunity to continue sharing our excitement about the redun workflow engine we open sourced last year.
Daphne Koller retweeted
Thanks to the AWS team for featuring Matt Rasmussen
(@mattrasmus), our VP Software Engineering, in today's HPC blog. We are grateful for the opportunity to continue sharing our excitement about the redun workflow engine we open sourced last year.
I have always enjoyed my conversations with the smart folks at @insitro. In this post, @mattrasmus talks about their data science workflows that run on AWS Batch. aws.amazon.com/blogs/hpc/dat…
Daphne Koller retweeted
#AI in drug discovery has incredible potential, but it remains hard and some of the hype may not be grounded in reality. Our CEO and founder @DaphneKoller spoke with @MaxGelman about why she believes the industry needs to calibrate people's expectations with what's possible.
Despite a flood of companies entering the AI space, the field has little hard data to show for itself, at least as far as the public can see. And that begs the question: How much of the “AI revolution” is hype, and how much is grounded in reality?
endpts.com/biopharma-has-hyp…
Excited to share redun with data scientists everywhere. We hope redun will help democratize data science at scale, and support robust, reproducible science.
We're excited to announce the open sourcing of redun, an expressive, efficient, and easy-to-use workflow framework designed to deal with complex, rapidly evolving scientific workflows spanning multiple data types. Read more here: insitro.medium.com/8b06b707a…
From an aspirational concept to 77M learners in 9 years. I feel proud to have been able to help learners around the world transform their lives via access to the best learning. It's a privilege to have had an opportunity to create this much impact on so many.
A major milestone in our journey, enabled by the many accomplishments of amazing insitrocytes and support of outstanding, long-term investors. We are excited to continue towards our goal of using #ML and data at scale to bring transformative #medicines to patients.
We're thrilled to announce our $400M Series C financing, which will greatly enable us to continue advancing our vision to reshape the discovery and development of transformative medicines by leveraging #machinelearning and biology and chemistry at scale. bwnews.pr/3eL7G7v
Thanks @_RobToews for including me in your @Forbes article and letting me talk about our work about our work at @insitro on using #ML for drug discovery. Honored to be included with a group of such amazing women scientists.
bit.ly/3qU1DBa
Daphne Koller retweeted
Christina Warren (@Film_Girl), and I wrap up 2020’s #BehindTheTech with a few of the fascinating guests we've had on the podcast this year. Hear from leaders in a wide range of tech sectors – from #ArtificialIntelligence to synthetic biology. msft.it/6008pRIar
Very proud to be included in Academic Influence's list of "Top 40 women in STEM", along with some incredible (women) scientists. bit.ly/3jEgWsQ #scientists
I'm truly excited to go back to education with today's launch of Engageli, a truly immersive, digital learning platform that helps students learn and teachers teach online. We are hoping to make education accessible and successful for all students. bit.ly/373ARi9